Valuation : SciBase Holding AB

Market Cap 171M 17.69M 15.24M 14.44M 13.06M 24.54M 1.69B 24.67M 65.87M 859M 66.42M 64.95M 2.74B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 171M 17.69M 15.24M 14.44M 13.06M 24.54M 1.69B 24.67M 65.87M 859M 66.42M 64.95M 2.74B EV / Sales 2026 *
2.81x
EV / Sales 2027 * 1.75x
Free-Float
35.06%
Yield 2026 *
-
Yield 2027 * -
1 day-7.20%
1 week-6.94%
Current month-13.66%
1 month-40.18%
3 months-66.50%
6 months-38.87%
Current year-51.45%
1 week 16.75
Extreme 16.75
19.2
1 month 16.75
Extreme 16.75
30
Current year 16.75
Extreme 16.75
54
1 year 16.75
Extreme 16.75
54
3 years 16.75
Extreme 16.75
129.8
5 years 16.75
Extreme 16.75
634
10 years 16.75
Extreme 16.75
2,860
Manager TitleAgeSince
Chief Executive Officer 59 2023-09-30
Director of Finance/CFO 64 2013-12-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 2017-05-15
Chairman 66 2024-06-12
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
-7.20%-6.94%-54.73%-81.59% 19.1M
+0.87%-4.86%+16.71%-33.27% 16.65B
-1.77%+7.05%-31.49%+58.12% 1.78B
+0.08%-3.83%-28.36%+19.34% 894M
-3.05%-15.43%-57.37%-84.22% 833M
-0.05%-0.32%+68.43%-3.30% 778M
-2.56%-5.08%-37.23%-49.60% 654M
-5.26%-9.30%-44.97%-48.89% 591M
+3.41%-15.78%-44.42%-39.91% 436M
+1.82%-5.18%+67.02%+48.52% 386M
Average -1.37%-6.43%-14.64%-21.48% 2.3B
Weighted average by Cap. +0.26%-4.95%+6.81%-24.64%

Financials

2026 *2027 *
Net sales 60.9M 6.29M 5.42M 5.13M 4.64M 8.73M 601M 8.77M 23.42M 305M 23.62M 23.09M 973M 97.7M 10.09M 8.7M 8.24M 7.45M 14M 964M 14.07M 37.58M 490M 37.89M 37.05M 1.56B
Net income -97.5M -10.07M -8.68M -8.22M -7.43M -13.97M -962M -14.05M -37.5M -489M -37.81M -36.97M -1.56B -69.7M -7.2M -6.2M -5.88M -5.31M -9.99M -688M -10.04M -26.81M -349M -27.03M -26.43M -1.11B
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
50
Date Price Change Volume
26-09-11 SEK 16.75 -7.20% 8,647
26-09-10 SEK 18.05 -0.82% 1,479
26-09-09 SEK 18.20 -0.55% 3,298
26-09-08 SEK 18.30 -1.08% 7,064
26-09-07 SEK 18.50 -1.86% 511

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!